Lv11
30 积分 2023-09-12 加入
Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)
4小时前
待确认
The evolving landscape of obesity pharmacotherapy
13天前
已完结
Recommendations for Systematic Statistical Computation of Immunogenicity Cut Points
19天前
已完结
Elimination of alkaline phosphatases from circulation by the galactose receptor. Different isoforms are cleared at various rates
1个月前
已完结
Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women
1个月前
已完结
Obesity phenotypes and atherogenic dyslipidemias
1个月前
已完结
Obesity and Dyslipidemia
1个月前
已完结
Early Use of PCSK9 Inhibitors in the Prognosis of Patients with Acute Coronary Syndrome by Protecting Vascular Endothelial Function
1个月前
已完结
Beyond lipid levels: unraveling the hypertensive factor in familial hypercholesterolemia. The HELLAS-FH registry
1个月前
已完结
Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease
1个月前
已完结
皖公网安备34019202002308
